Science Corporation
Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases
$230MSeries C
Role not disclosedI
IQT
Activity from announced rounds
Activity in this selectionSeries C+
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $230M 1 disclosed · full round size, not this investor’s share